Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients
Clinical trial NCT03569280 · COMPLETED
Trial details
- NCT number
- NCT03569280
- Sponsor
- Kangpu Biopharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-26
- Primary completion
- 2023-01-10
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.